US 10654829
Crystalline forms and compositions of CFTR modulators
granted A61KA61K9/10A61K9/2013
Quick answer
US patent 10654829 (Crystalline forms and compositions of CFTR modulators) held by Vertex Pharmaceuticals Incorporated expires Mon May 14 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue May 19 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 14 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 23
- CPC classes
- A61K, A61K9/10, A61K9/2013, A61K9/2054, A61P